(4-chlorophenethyl)(p-tolyl)sulfane

• 分子结构分类: 有机化合物 - 有机硫化合物 - 硫醚类
• 英文名称: (4-chlorophenethyl)(p-tolyl)sulfane
• 英文别名: 1-Chloro-4-[2-(4-methylphenyl)sulfanylethyl]benzene；1-chloro-4-[2-(4-methylphenyl)sulfanylethyl]benzene
• 化学式: C₁₅H₁₅ClS
• 分子量: 262.803
• InChiKey: OZQPICSFIVMPSA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.4
• 重原子数：
  17
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  25.3
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  (4-chlorophenethyl)(p-tolyl)sulfane 在 碘苯 、 silver(I) acetate 、 溶剂黄146 、 间氯过氧苯甲酸 、 palladium dichloride 作用下， 以 二氯甲烷 、 1,1,2,2-四氯乙烷 为溶剂， 反应 61.0h， 生成 10-chloro-2-methyl-6,7-dihydrodibenzo[b,d]thiepine 5-oxide
  参考文献：
  名称：

  Synthesis of Sulfur-Bridged Polycycles via Pd-Catalyzed Dehydrogenative Cyclization

  摘要：

  A general approach to sulfur-bridged polycycles by palladium-catalyzed double C(sp(2))-H bond oxidative cyclization is presented. This protocol afforded diverse sulfur-bridged five-, six-, and seven-membered polycycles in moderate to good yields with a tolerance for a wide variety of functional groups. A sulfide-bridged six-membered pyrene-thienoacene compound was synthesized readily using this method, and excellent performance for photoluminescence quantum yield was observed.

  DOI：

  10.1021/ol502127j
• 作为产物：
  描述：

  4-氯苯乙烯 、 4-甲苯硫酚 在 zinc(II) chloride 作用下， 以 二氯甲烷 为溶剂， 反应 18.0h， 以75%的产率得到(4-chlorophenethyl)(p-tolyl)sulfane
  参考文献：
  名称：

  硫醇对炔烃双氢磺基化锌催化合成二硫缩醛

  摘要：

  锌催化烯烃氢磺基化反应可以在多种溶剂中进行，并通过区域选择性得到相应的产物。炔烃与硫醇的二氢硫基化也可以通过使用锌催化剂来实现，并且该反应优先于单氢硫基化。该反应还可以区域选择性地以优异的产率得到二硫代缩醛。

  DOI：

  10.1055/s-0037-1610302

文献信息

• Acid/Phosphide-Induced Radical Route to Alkyl and Alkenyl Sulfides and Phosphonothioates from Sodium Arylsulfinates in Water
  作者：Ya-mei Lin、Guo-ping Lu、Gui-xiang Wang、Wen-bin Yi

  DOI：10.1021/acs.joc.6b02459

  日期：2017.1.6

  can in situ generate arylsulfenyl radicals. These radicals have high reactivity to react with alkynes, alkenes, and H-phosphine oxides for the synthesis of alkyl and alkenyl sulfides and phosphonothioates. The control experiments and quantum calculations are also performed to gain insights into the generation mechanism of arylsulfenyl radicals. Notably, the chemistry is free of thiol odors, organic solvents

  引入了一种新开发的含有酸和磷的水性体系，在该体系中，无味且稳定的芳基亚磺酸钠可以原位生成芳基亚硫基。这些自由基具有与炔烃，烯烃和H-膦氧化物反应的高反应性，以合成烷基硫化物和烯基硫化物以及硫代磷酸硫代酸酯。还进行了控制实验和量子计算，以深入了解芳基亚硫基自由基的生成机理。值得注意的是，该化学物质不含硫醇气味，有机溶剂和金属。
• A recyclable self-assembled composite catalyst consisting of Fe₃O₄-rose bengal-layered double hydroxides for highly efficient visible light photocatalysis in water
  作者：Yuxing Huang、Zhuo Xin、Wenlong Yao、Qi Hu、Zhuohua Li、Liuqing Xiao、Bo Yang、Junmin Zhang

  DOI：10.1039/c8cc08130a

  日期：——

  The first case of a highly efficient layered double hydroxide (LDH) supported organic visible light photocatalyst is reported and it can catalyze various organic transformations with high efficiency in water under visible light irradiation.

  报道了第一种高效的层状双氢氧化物（LDH）负载的有机可见光光催化剂，它可以在可见光照射下高效催化水中的各种有机转化。
• GLYCOPEPTIDE COMPOUNDS HAVING ACTIVITY OF RESISTING DRUG-RESISTANT BACTERIA, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
  申请人：Shanghai LaiYi Center For Biopharmaceutical R&D Co., Ltd.

  公开号：EP3763728A1

  公开（公告）日：2021-01-13

  The present invention discloses glycopeptide compounds having activity of resisting drug-resistant bacteria, conforming to glycopeptide compounds represented by general formula (I), The present invention also provides a preparation method for and an application of the glycopeptide compounds. Upon testing, compared with a second-generation glycopeptide drug oritavancin, the glycopeptide antibiotic compounds have higher inhibition activity on drug-resistant bacterial strains, especially MRSA or VRE. Further testing shows that most of the glycopeptide compounds have safety higher than that of oritavancin and can be prepared into drugs for treating or preventing diseases caused by various bacterial infections, such as skin and soft tissue infections, meningitis, sepsis, pneumonia, arthritis, peritonitis, bronchitis, and empyema,

  本发明公开了具有抗耐药性细菌活性的糖肽化合物，符合通式（I）所代表的糖肽化合物、 本发明还提供了糖肽化合物的制备方法和应用。经测试，与第二代糖肽药物奥利他万星（oritavancin）相比，糖肽抗生素化合物对耐药菌株，尤其是 MRSA 或 VRE 具有更高的抑制活性。进一步的测试表明，大多数糖肽化合物的安全性高于奥利他万星，可以制备成药物，用于治疗或预防各种细菌感染引起的疾病，如皮肤和软组织感染、脑膜炎、败血症、肺炎、关节炎、腹膜炎、支气管炎和肺水肿、
• Glycopeptide Compounds Having Activity Of Resisting Drug-Resistant Bacteria, And Preparation Method And Application Thereof
  申请人：Shanghai LaiYi Center For Biopharmaceutical R&D Co

  公开号：US20210093691A1

  公开（公告）日：2021-04-01

  The present invention discloses glycopeptide compounds having activity of resisting drug-resistant bacteria, conforming to glycopeptide compounds represented by general formula (I), The present invention also provides a preparation method for and an application of the glycopeptide compounds. Upon testing, compared with a second-generation glycopeptide drug oritavancin, the glycopeptide antibiotic compounds have higher inhibition activity on drug-resistant bacterial strains, especially MRSA or VRE. Further testing shows that most of the glycopeptide compounds have safety higher than that of oritavancin and can be prepared into drugs for treating or preventing diseases caused by various bacterial infections, such as skin and soft tissue infections, meningitis, sepsis, pneumonia, arthritis, peritonitis, bronchitis, and empyema.